Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ICON, a clinical research organization, has acquired a 33,000-square-foot Phase I facility with a capacity of up to 100 beds in Omaha, Nebraska, having acquired the assets of the former Qualia Clinical Services.
Subscribe to our email newsletter
ICON has also appointed Gary Curtis as its new senior vice president of global clinical pharmacology. Dr Curtis will integrate the Omaha facility with ICON’s existing Phase I units and will be supported by key clinical operational staff from Qualia who have been rehired by ICON.
Thomas Frey, president of development solutions at ICON, said: “This latest acquisition supports our strategy of expanding our Phase I capabilities in the US and brings our total bed capacity there to approximately 225 beds. We have acquired an excellent facility and we have put in place an experienced team who will ensure the delivery of quality clinical pharmacology services to clients.”